Your browser doesn't support javascript.
loading
A Phase II Trial of 5-Day Neoadjuvant Radiotherapy for Patients with High-Risk Primary Soft Tissue Sarcoma.
Kalbasi, Anusha; Kamrava, Mitchell; Chu, Fang-I; Telesca, Donatello; Van Dams, Ritchell; Yang, Yingli; Ruan, Dan; Nelson, Scott D; Dry, Sarah M; Hernandez, Jackie; Chmielowski, Bartosz; Singh, Arun S; Bukata, Susan V; Bernthal, Nicholas M; Steinberg, Michael L; Weidhaas, Joanne B; Eilber, Fritz C.
Affiliation
  • Kalbasi A; Department of Radiation Oncology, University of California Los Angeles (UCLA), Los Angeles, California. anushakalbasi@mednet.ucla.edu fceilber@mednet.ucla.edu.
  • Kamrava M; Division of Surgical-Oncology, Department of Surgery, University of California Los Angeles, Los Angeles, California.
  • Chu FI; University of California Los Angeles Jonsson Comprehensive Cancer Center Sarcoma Program, Los Angeles, California.
  • Telesca D; Cedars-Sinal Medical Center, Los Angeles, California.
  • Van Dams R; Department of Radiation Oncology, University of California Los Angeles (UCLA), Los Angeles, California.
  • Yang Y; Department of Biostatistics, University of California Los Angeles Fielding School of Public Health, Los Angeles, California.
  • Ruan D; Department of Radiation Oncology, University of California Los Angeles (UCLA), Los Angeles, California.
  • Nelson SD; Department of Radiation Oncology, University of California Los Angeles (UCLA), Los Angeles, California.
  • Dry SM; Department of Radiation Oncology, University of California Los Angeles (UCLA), Los Angeles, California.
  • Hernandez J; University of California Los Angeles Jonsson Comprehensive Cancer Center Sarcoma Program, Los Angeles, California.
  • Chmielowski B; Department of Pathology, University of California Los Angeles, Los Angeles, California.
  • Singh AS; University of California Los Angeles Jonsson Comprehensive Cancer Center Sarcoma Program, Los Angeles, California.
  • Bukata SV; Department of Pathology, University of California Los Angeles, Los Angeles, California.
  • Bernthal NM; Department of Radiation Oncology, University of California Los Angeles (UCLA), Los Angeles, California.
  • Steinberg ML; University of California Los Angeles Jonsson Comprehensive Cancer Center Sarcoma Program, Los Angeles, California.
  • Weidhaas JB; Division of Hematology-Oncology, Department of Medicine, University of California Los Angeles, Los Angeles, California.
  • Eilber FC; Division of Surgical-Oncology, Department of Surgery, University of California Los Angeles, Los Angeles, California.
Clin Cancer Res ; 26(8): 1829-1836, 2020 04 15.
Article in En | MEDLINE | ID: mdl-32054730
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiotherapy Dosage / Sarcoma / Soft Tissue Neoplasms / Wounds and Injuries / Neoadjuvant Therapy / Polymorphism, Single Nucleotide / MicroRNAs Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2020 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiotherapy Dosage / Sarcoma / Soft Tissue Neoplasms / Wounds and Injuries / Neoadjuvant Therapy / Polymorphism, Single Nucleotide / MicroRNAs Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2020 Document type: Article Country of publication: United States